banner
Integrin inhibitor, Cyclo(-RGDyK), Purity ≥98%
Inquiry

Cat. No.: X24-08-YM313

Integrin inhibitor, Cyclo(-RGDyK), Purity ≥98%

Synonym: 217099-14-4; Cyclo(RGDyK); cyclo[Arg-Gly-Asp-D-Tyr-Lys]; Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) trifluoroacetate salt; 2-[(2S,5R,8S,11S)-8-(4-Aminobutyl)-11-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

  • CAS Number: 217099-14-4
  • Compound CID: 11157853
img
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Cyclo(-RGDyK) is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin. It targets the αvβ3.
Molecular Weight
619.67
Targets
αvβ3: 20 nM (IC50)
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Cyclo(-RGDyK) is a cytoskeletal signaling inhibitor that plays a key role in research to study integrin-mediated cell adhesion and migration.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0